Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases

Remdesivir is a broad-spectrum antiviral nucleotide prodrug that has been clinically evaluated in Ebola virus patients and recently received emergency use authorization (EUA) for treatment of COVID-19. With approvals from the Federal Select Agent Program and the Centers for Disease Control and Preve...

Descripción completa

Detalles Bibliográficos
Autores principales: Lo, Michael K., Albariño, César G., Perry, Jason K., Chang, Silvia, Tchesnokov, Egor P., Guerrero, Lisa, Chakrabarti, Ayan, Shrivastava-Ranjan, Punya, Chatterjee, Payel, McMullan, Laura K., Martin, Ross, Jordan, Robert, Götte, Matthias, Montgomery, Joel M., Nichol, Stuart T., Flint, Mike, Porter, Danielle, Spiropoulou, Christina F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2020
Materias:
Biological Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604432/
https://www.ncbi.nlm.nih.gov/pubmed/33028676
http://dx.doi.org/10.1073/pnas.2012294117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604432/
https://www.ncbi.nlm.nih.gov/pubmed/33028676
http://dx.doi.org/10.1073/pnas.2012294117

Ejemplares similares